Get the Stockscreener App
1.60
2.56%
0.04
After Hours:
1.62
0.02
+1.25%
Pulmonx Corp stock is traded at $1.60, with a volume of 931.03K.
It is up +2.56% in the last 24 hours and down -49.21% over the past month.
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
See More
Previous Close:
$1.56
Open:
$1.56
24h Volume:
931.03K
Relative Volume:
1.67
Market Cap:
$65.19M
Revenue:
$68.68M
Net Income/Loss:
$-60.84M
P/E Ratio:
-1.00
EPS:
-1.6
Net Cash Flow:
$-38.42M
1W Performance:
+3.23%
1M Performance:
-49.21%
6M Performance:
-77.11%
1Y Performance:
-75.65%
1-Day Range:
$1.56
$1.655
1-Week Range:
$1.47
$1.655
52-Week Range:
$1.47
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
Name
Pulmonx Corp
Sector
Industry
Phone
650-364-0400
Address
700 CHESAPEAKE DRIVE, REDWOOD CITY
Compare LUNG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.60 | 63.56M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
130.27 | 229.31B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.05 | 152.87B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
381.61 | 146.01B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.81 | 119.18B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.30 | 45.95B | 5.69B | 1.41B | 577.90M | 6.95 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-10-25 | Initiated | D. Boral Capital | Buy |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-04-24 | Initiated | Lake Street | Buy |
| Feb-23-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Sep-05-23 | Initiated | Craig Hallum | Buy |
| Feb-27-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Mar-25-21 | Initiated | Piper Sandler | Neutral |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-26-20 | Initiated | BofA Securities | Buy |
| Oct-26-20 | Initiated | Canaccord Genuity | Buy |
| Oct-26-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-26-20 | Initiated | Stifel | Buy |
| Oct-26-20 | Initiated | Wells Fargo | Equal Weight |
View All
Pulmonx Corp Stock (LUNG) Latest News
How to read the order book for Pulmonx Corporation2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
Order flow analysis tools used on Pulmonx CorporationBond Market & Long-Term Safe Investment Plans - Newser
Chart overlay techniques for tracking Pulmonx CorporationShort Setup & Accurate Technical Buy Alerts - Newser
Published on: 2025-08-17 14:40:16 - Newser
What momentum shifts mean for Pulmonx CorporationJuly 2025 Institutional & Consistent Profit Alerts - Newser
Real time alert setup for Pulmonx Corporation performanceAnalyst Upgrade & Proven Capital Preservation Methods - Newser
Analyzing Pulmonx Corporation with risk reward ratio chartsSell Signal & Weekly Return Optimization Plans - Newser
Will Breakout in Pulmonx Corporation Sustain Through Next WeekWeekly Profit Analysis & AI Powered Market Trend Analysis - newsyoung.net
Volatility clustering patterns for Pulmonx CorporationOil Prices & High Return Trade Opportunity Guides - Newser
Will Pulmonx Corporation bounce back from current support2025 Investor Takeaways & Low Volatility Stock Recommendations - Newser
Pulmonx Corporation Earnings Report Breakdown: What Investors Should KnowTrade Risk Assessment & Expert Curated Trade Setups - Newser
Pulmonx's Strategic Initiatives and Revenue Growth Support Buy Rating - AInvest
Will breakout in Pulmonx Corporation lead to full recovery2025 Winners & Losers & Free Community Supported Trade Ideas - Newser
Pulmonx Corporation stock trend outlook and recovery pathPortfolio Return Report & Fast Momentum Stock Entry Tips - Newser
Pulmonx at Canaccord Conference: Growth Plans Amid Challenges By Investing.com - Investing.com Nigeria
Pulmonx at Canaccord Conference: Growth Plans Amid Challenges - Investing.com
Chart based exit strategy for Pulmonx CorporationWeekly Risk Summary & Fast Exit/Entry Strategy Plans - Newser
Developing predictive dashboards with Pulmonx Corporation dataWeekly Trade Review & Long-Term Safe Investment Plans - Newser
After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG) - Yahoo Finance
What catalysts could drive Pulmonx Corporation stock higher in 2025Triple-digit returns - Jammu Links News
Pulmonx (NASDAQ:LUNG) Cut to Neutral at Piper Sandler - Defense World
Pulmonx (LUNG) Q2 Revenue Rises 15% - AOL.com
What the charts say about Pulmonx Corporation todayFree Triple Return Setup with Risk Control - Newser
Analysts Have Lowered Expectations For Pulmonx Corporation (NASDAQ:LUNG) After Its Latest Results - 富途牛牛
Pulmonx Corp SEC 10-Q Report - TradingView
Pulmonx Corporation (NASDAQ:LUNG) Q2 2025 Earnings Call Transcript - Insider Monkey
Pulmonx Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Pulmonx Corp (LUNG) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com
Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings - Benzinga
Will GRDN price bounce be sustainableStrong Buy Opportunity with Volume Support - Newser
Should I buy Riverview Bancorp Inc. stock before earningsReal-Time AI Sentiment and Price Forecast - Newser
Pulmonx Corp (LUNG) Q2 2025 Earnings Call Highlights: Strong International Growth Amid US Challenges - Yahoo Finance
Piper Sandler downgrades Pulmonx stock to Neutral on growth concerns By Investing.com - Investing.com Nigeria
Piper Sandler downgrades Pulmonx stock to Neutral on growth concerns - Investing.com India
What to expect from Pulmonx Corporation in the next 30 daysSwing Gain Strategy with Entry Forecast - Newser
CNB Financial Corporation stock retracement – recovery analysisPortfolio Risk Distribution Analysis Tool - Newser
Is Canada Goose Holdings Inc. showing signs of accumulationWeekly Return Plan for Conservative Traders - Newser
Tools to monitor Pulmonx Corporation recovery probabilityFree Real-Time Analysis With Entry Targets - Newser
Earnings call transcript: Pulmonx reports Q2 2025 revenue beat, stock gains - Investing.com Canada
Earnings call transcript: Pulmonx reports Q2 2025 revenue beat, stock gains By Investing.com - Investing.com South Africa
Pulmonx Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Pulmonx earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Option Care Health Inc. Building a Base Near SupportBreakout Confirmation With Entry Tracker Enabled - metal.it
Can trapped investors hope for a rebound in Sally Beauty Holdings Inc.Intraday Price Forecast Using Volume Models - Newser
Is Delek US Holdings Inc. stock ready for a breakoutVolume Confirmed Setup with Entry Confidence - Newser
Leading Lung Disease Treatment Company Pulmonx Showcases Growth Story at Major Healthcare Conference - Stock Titan
Why SL Green Realty Corp. stock is on top investor watchlistsSector Rotation and Stock Opportunity Analysis - Newser
Price Channel Expanding on Pulmonx Corporation’s ChartCapital Preserving Trade Plan Templates Shared - metal.it
Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference - Yahoo Finance
Pulmonx Corp Stock (LUNG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.56%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):